DGX vs XNCR · P/E 22, rev $5.94B vs rev $55.7M
Quest Diagnostics Incorporated (DGX) versus Xencor Inc (XNCR) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Xencor Inc (XNCR) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported XNCR revenue for 2026-06-30 was $55.7M. Net income was -$150.6M. XNCR currently screens at market cap $664.0M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. XNCR currently screens at market cap $664.0M.
Not investment advice. Open the DGX and XNCR stock pages for the full models.
Not investment advice.